ANTIOXIDANTS AND ATHEROSCLEROSIS - A CURRENT ASSESSMENT

[1] BAKER SG, 1982, S AFR MED J, V62, P7

[2] THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 15 - 22

[3] BUXTORF JC, 1985, SEM HOP PARIS, V61, P837

[4] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[5] CATHCART MK, 1989, J IMMUNOL, V142, P1963

[6] MONOCYTES AND NEUTROPHILS OXIDIZE LOW-DENSITY LIPOPROTEIN MAKING IT CYTO-TOXIC [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (02) : 341 - 350

[7] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138

[8] PROBUCOL ATTENUATES THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) : 612 - 618

[9] MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04): : 2214 - 2218

[10] MECHANISMS OF HDL REDUCTION AFTER PROBUCOL - CHANGES IN HDL SUBFRACTIONS AND INCREASED REVERSE CHOLESTERYL ESTER TRANSFER [J]. ARTERIOSCLEROSIS, 1989, 9 (04): : 462 - 469

[1] BAKER SG, 1982, S AFR MED J, V62, P7

[2] THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 15 - 22

[3] BUXTORF JC, 1985, SEM HOP PARIS, V61, P837

[4] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729

[5] CATHCART MK, 1989, J IMMUNOL, V142, P1963

[6] MONOCYTES AND NEUTROPHILS OXIDIZE LOW-DENSITY LIPOPROTEIN MAKING IT CYTO-TOXIC [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (02) : 341 - 350

[7] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138

[8] PROBUCOL ATTENUATES THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) : 612 - 618

[9] MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04): : 2214 - 2218

[10] MECHANISMS OF HDL REDUCTION AFTER PROBUCOL - CHANGES IN HDL SUBFRACTIONS AND INCREASED REVERSE CHOLESTERYL ESTER TRANSFER [J]. ARTERIOSCLEROSIS, 1989, 9 (04): : 462 - 469